Envestnet Asset Management Inc Xencor Inc Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$25.95 - $36.95 $1.7 Million - $2.42 Million
65,587 Added 388.94%
82,450 $2.3 Million
Q4 2022

Feb 07, 2023
SELL
$24.79 - $30.86 $6,420 - $7,992
-259 Reduced 1.51%
16,863 $439,000
Q3 2022

Nov 10, 2022
BUY
$24.62 - $32.44 $421,543 - $555,437
17,122 New
17,122 $445,000

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email